Long-term safety, efficacy, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G in patients aged ≥ 18 years with primary immunodeficiencies / Richard L. Wasserman ... [et al.]. Klinická imunológia a alergológia Zv. 25, č. 3 (2015), s. 38